HomePharma & Biotech

Pharma & Biotech

Gerresheimer’s Countdown to June: Audited Accounts Are the Only Cure

Analysis April 26, 2026

Bayer’s Legal Tightrope: Supreme Court Showdown Meets a €7 Billion Capital Cushion

Analysis April 26, 2026

BioNTech’s Defining Fortnight: Insider Sales, Founder Exodus, and a Pipeline Under the Microscope

Earnings April 26, 2026

Valneva Faces a Test of Resilience as Legal Clouds and Analyst Skepticism Gather

Analysis April 26, 2026

Gerresheimer Faces a Defining June as Creditors Grant Breathing Room

Earnings April 25, 2026

Bayer’s Dividend Stays at Minimum as Supreme Court Glyphosate Hearing Looms

Chemicals April 25, 2026

Novo Nordisk’s Twin Clinical Wins Mask a Bruising Year and a Looming Medicare Showdown

Analysis April 25, 2026

BioNTech’s €17 Billion War Chest Faces a Defining May as Insider Sale Precedes Earnings

Earnings April 24, 2026

1...222324...101 Page 23 of 101